ID SPI2B_HUMAN Reviewed; 258 AA. AC Q9BPZ2; Q7Z2M0; DT 10-OCT-2002, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 22-APR-2020, entry version 140. DE RecName: Full=Spindlin-2B; DE AltName: Full=Spindlin-like protein 2B; DE Short=SPIN-2; DE Short=SPIN-2B; GN Name=SPIN2B; Synonyms=SPIN2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=12145692; DOI=10.1038/sj.leu.2402557; RA Fletcher B.S., Dragstedt C., Notterpek L., Nolan G.P.; RT "Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles RT in cell cycle progression."; RL Leukemia 16:1507-1518(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., RA Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., RA Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., RA Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., RA Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., RA Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., RA Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., RA Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., RA Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., RA Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., RA Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., RA Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., RA Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., RA Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., RA Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., RA Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., RA Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., RA Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., RA Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., RA Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., RA Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., RA Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., RA Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., RA Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., RA Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., RA Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., RA Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., RA Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., RA Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., RA Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., RA Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., RA Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., RA d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., RA Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., RA Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., RA Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., RA Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., RA Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., RA Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., RA Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Mammary gland, and Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, AND INTERACTION WITH C11ORF84/SPINDOC. RX PubMed=29061846; DOI=10.1074/jbc.m117.814913; RA Bae N., Gao M., Li X., Premkumar T., Sbardella G., Chen J., Bedford M.T.; RT "A transcriptional coregulator, SPIN-DOC, attenuates the coactivator RT activity of Spindlin1."; RL J. Biol. Chem. 292:20808-20817(2017). CC -!- FUNCTION: Involved in the regulation of cell cycle progression, this CC activity is related to the inhibition of apoptosis following the CC removal of essential growth factors (PubMed:12145692). Exhibits CC H3K4me3-binding activity (PubMed:29061846). CC {ECO:0000269|PubMed:12145692, ECO:0000269|PubMed:29061846}. CC -!- SUBUNIT: Interacts with C11orf84/SPINDOC (PubMed:29061846). CC {ECO:0000269|PubMed:29061846}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12145692}. CC -!- TISSUE SPECIFICITY: Detected in all the examined tissues with highest CC expression in liver, followed by heart, stomach, kidney, skeletal CC muscle, placenta, and pancreas. CC -!- MISCELLANEOUS: Overexpression in murine myeloid cell line 32Dcl3 causes CC G2/M arrest. CC -!- SIMILARITY: Belongs to the SPIN/STSY family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF356353; AAK37566.1; -; mRNA. DR EMBL; AL022157; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC000044; AAH00044.1; -; mRNA. DR EMBL; BC071974; AAH71974.1; -; mRNA. DR CCDS; CCDS35311.1; -. DR RefSeq; NP_001006682.1; NM_001006681.1. DR RefSeq; NP_001006683.1; NM_001006682.1. DR RefSeq; NP_001006684.1; NM_001006683.1. DR RefSeq; XP_005262066.2; XM_005262009.4. DR RefSeq; XP_005262067.1; XM_005262010.1. DR RefSeq; XP_011529090.1; XM_011530788.2. DR RefSeq; XP_016885041.1; XM_017029552.1. DR PDB; 5LUG; X-ray; 1.70 A; A/B/C/D=44-258. DR PDBsum; 5LUG; -. DR SMR; Q9BPZ2; -. DR BioGrid; 138877; 24. DR IntAct; Q9BPZ2; 18. DR STRING; 9606.ENSP00000335008; -. DR iPTMnet; Q9BPZ2; -. DR PhosphoSitePlus; Q9BPZ2; -. DR BioMuta; SPIN2B; -. DR DMDM; 23822181; -. DR EPD; Q9BPZ2; -. DR jPOST; Q9BPZ2; -. DR MassIVE; Q9BPZ2; -. DR MaxQB; Q9BPZ2; -. DR PaxDb; Q9BPZ2; -. DR PeptideAtlas; Q9BPZ2; -. DR PRIDE; Q9BPZ2; -. DR ProteomicsDB; 78597; -. DR Antibodypedia; 26988; 69 antibodies. DR DNASU; 474343; -. DR Ensembl; ENST00000275988; ENSP00000275988; ENSG00000186787. DR Ensembl; ENST00000333933; ENSP00000335008; ENSG00000186787. DR GeneID; 474343; -. DR KEGG; hsa:474343; -. DR UCSC; uc004duy.5; human. DR CTD; 474343; -. DR GeneCards; SPIN2B; -. DR HGNC; HGNC:33147; SPIN2B. DR HPA; ENSG00000186787; Low tissue specificity. DR MIM; 300517; gene. DR neXtProt; NX_Q9BPZ2; -. DR PharmGKB; PA162404530; -. DR eggNOG; ENOG410IGUH; Eukaryota. DR eggNOG; ENOG410XQI2; LUCA. DR GeneTree; ENSGT00950000182925; -. DR HOGENOM; CLU_068595_0_0_1; -. DR InParanoid; Q9BPZ2; -. DR OMA; NTQEAEG; -. DR OrthoDB; 1027563at2759; -. DR PhylomeDB; Q9BPZ2; -. DR TreeFam; TF332665; -. DR GenomeRNAi; 474343; -. DR Pharos; Q9BPZ2; Tdark. DR PRO; PR:Q9BPZ2; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; Q9BPZ2; protein. DR Bgee; ENSG00000186787; Expressed in fundus of stomach and 91 other tissues. DR ExpressionAtlas; Q9BPZ2; baseline and differential. DR Genevisible; Q9BPZ2; HS. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0035064; F:methylated histone binding; IDA:UniProtKB. DR GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0007276; P:gamete generation; IEA:InterPro. DR GO; GO:0051726; P:regulation of cell cycle; IEA:InterPro. DR GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central. DR Gene3D; 2.80.10.70; -; 1. DR InterPro; IPR029564; SPIN-2. DR InterPro; IPR003671; SPIN/Ssty. DR InterPro; IPR042567; SPIN/Ssty_sf. DR PANTHER; PTHR10405; PTHR10405; 1. DR PANTHER; PTHR10405:SF13; PTHR10405:SF13; 1. DR Pfam; PF02513; Spin-Ssty; 3. PE 1: Evidence at protein level; KW 3D-structure; Apoptosis; Cell cycle; Nucleus; Reference proteome. FT CHAIN 1..258 FT /note="Spindlin-2B" FT /id="PRO_0000181369" FT REGION 50..99 FT /note="Tudor-like domain 1" FT /evidence="ECO:0000255" FT REGION 129..178 FT /note="Tudor-like domain 2" FT /evidence="ECO:0000255" FT REGION 138 FT /note="Histone H3K4me3 and H3R8me2a binding" FT /evidence="ECO:0000250|UniProtKB:Q9Y657" FT REGION 210..255 FT /note="Tudor-like domain 3" FT /evidence="ECO:0000255" FT REGION 246..248 FT /note="Histone H3K4me3 and H3R8me2a binding" FT /evidence="ECO:0000250|UniProtKB:Q9Y657" FT BINDING 169 FT /note="Histone H3K4me3 and H3R8me2a" FT /evidence="ECO:0000250|UniProtKB:Q9Y657" FT BINDING 176 FT /note="Histone H3K4me3 and H3R8me2a" FT /evidence="ECO:0000250|UniProtKB:Q9Y657" FT BINDING 180 FT /note="Histone H3K4me3 and H3R8me2a" FT /evidence="ECO:0000250|UniProtKB:Q9Y657" FT STRAND 53..58 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 66..75 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 83..87 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 94..96 FT /evidence="ECO:0000244|PDB:5LUG" FT TURN 98..100 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 104..110 FT /evidence="ECO:0000244|PDB:5LUG" FT HELIX 122..128 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 132..138 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 142..154 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 156..158 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 161..166 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 169..175 FT /evidence="ECO:0000244|PDB:5LUG" FT HELIX 177..182 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 186..188 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 213..217 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 221..231 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 238..243 FT /evidence="ECO:0000244|PDB:5LUG" FT STRAND 250..253 FT /evidence="ECO:0000244|PDB:5LUG" SQ SEQUENCE 258 AA; 29158 MW; CAD74289970B4BCD CRC64; MKTPNAQEAE GQQTRAAAGR ATGSANMTKK KVSQKKQRGR PSSQPRRNIV GCRISHGWKE GDEPITQWKG TVLDQVPINP SLYLVKYDGI DCVYGLELHR DERVLSLKIL SDRVASSHIS DANLANTIIG KAVEHMFEGE HGSKDEWRGM VLAQAPIMKA WFYITYEKDP VLYMYQLLDD YKEGDLRIMP ESSESPPTER EPGGVVDGLI GKHVEYTKED GSKRIGMVIH QVEAKPSVYF IKFDDDFHIY VYDLVKKS //